Using a comparative approach analyzing different tumor subtypes from hematologic as well as epithelial origin, we demonstrate that all independent cancer patient groups studied uniformly show an expanded pool of CD4+CD127lowFOXP3+ Treg cells. The gene discussed is CD4; the disease is cancer.